Review of the effect of measles vaccination on the epidemiology of SSPE

International Journal of Epidemiology

Volumn 36, Issue 6, 2007, Pages 1334-1348

  Campbell, H ^a   Andrews, N ^a   Brown, K E ^a   Miller, E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Epidemiology; Genotype; Measles; Measles vaccine; MMR vaccine; SSPE; Subacute sclerosing panencephalitis; Vaccination

Indexed keywords

INACTIVATED VIRUS VACCINE; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE;

DISEASE TRANSMISSION; DISEASE TREATMENT; EPIDEMIOLOGY; IMMUNIZATION; MEASLES; VACCINATION;

DATA ANALYSIS; DEMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; ETHNICITY; GENETIC RISK; HEALTH PROGRAM; HEALTH PROMOTION; HERD IMMUNITY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; MUMPS; NONHUMAN; ONSET AGE; PERINATAL PERIOD; PREGNANCY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RUBELLA; SEX RATIO; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS LATENCY; VIRUS STRAIN;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REGISTRIES; SUBACUTE SCLEROSING PANENCEPHALITIS; WORLD HEALTH;

EID: 36949039030     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dym207     Document Type: Review

References (121)

1. Prashanth LK, Taly AB, Ravi V, Sinha S, Rao S. Long term survival in subacute sclerosing panencephalitis: An enigma. Brain Dev 2006; 28:447-52.
2. Centers for Disease Control (CDC). Subacute sclerosing panencephalitis surveillance - United States. MMWR Morb Mortal Wkly Rep 1982;31 585-88.
3. Katz SL. A vaccine-preventable infectious disease kills half a million children annually (Editorial). J Infect Dis 2005;192:1679-80.
4. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J 2002;78:63-70.
5. Bellman MH, Dick GW. Surveillance of subacute sclerosing panencephalitis. J R Coll Physicians Lond 1978;12:256-61.
6. WHO. New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec 2005;80:341-52.
7. Andrews N, Tischer A, Siedler A, Pebody R, Barbara C. Towards measles elimination: Measles susceptibility in seventeen European countries and Australia. Bull World Health Organ. In Press.
8. Miller C, Farrington CP, Harbert K. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. Int J Epidemiol 1992;21:998-1006.
9. Bellini WJ, Rota JS, Lowe LE et al. Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized. J infect Dis 2005;192:1686-93.
10. Zilber N, Rannon L, Alter M, Kahana E. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 1983;33:1558-64.
11. Lucas KM, Sanders RC, Rongap A, Rongap T, Pinai S, Alpers MP. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: A high incidence in young children. Epidemiol Infect 1992;108:547-53.
12. Schoub ED, Johnson S, McAnerney JM. Observations of subacute sclerosing panencephalitis in South Africa. Trans R Soc Trop Med Hyg 1992; 86:550-51.
13. Nakamura Y, Iinuma K, Oka E, Nihei K. [Epidemiologic features of subacute sclerosing panencephalitis from clinical data of patients receiving a public aid for treatment]. No To Hattatsu 2003;35 316-20. [Article in Japanese]
14. Mgone CS, Mgone JM, Takasu T et al. Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea. Trop Med Int Health 2003;8:219-27.
15. Procopis PG. Subacute sclerosing panencephalitis: A study of 25 patients. Proc Aust Assoc Neurol 1974;11:133-35.
16. Canal N, Torck P. An epidemiological study of subacute sclerosing leucoencephalitis in Belgium. J Neurol Sci 1964;1:380-89.
17. Nunes ML, Costa da Costa J, Stancher VM et al. Subacute sclerosing panencephalitis: Clinical aspects and prognosis. The Brazilian registry. Arq Neuropsiquiatr 1999;57:176-81.
18. Canelas HM, Juliao OF, Lefèvre AB et al. Subacute lrucoencephalitis: An epidemiological clinical and biochemical study of 31 cases. Arq Neuropsiquiatr 1967;25:255-68.
19. Bojinova V, Dimova P, Belopitova L, Mihailov A, Gatcheva N, Mihneva Z, Todorova M. Subacute sclerosing panencephalitis in Bulgaria (1978-2002). Neuroepidemiology 2004;23:254-57.
20. Roman G, Navarro de Roman L, Toro G, Vergara I. Subacute sclerosing panencephalitis in South America. Lancet 1976;2:1352-53.
21. Mordhorst C-H, Wulff CH. Cases of subacute sclerosing panencephalitis in Denmark 1970-79. Ugeskr Læyer 1981;143:3460-63.
22. Miller C, Andrews N, Rush M, Munro H, Jin L, Miller E. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002. Arch Dis Child 2004;89:1145-48.
23. Pettay O, Donner M, Halonen H, Palosuo T, Salmi A. Subacute sclerosing panencephalitis: Preceding intellectual deterioration & deviant measles serology. J Infect Dis 1971;124:439-44.
24. Vucenovic V, Vranjesevic D. SSPE-epidemiology and measles vaccination: our cases. Neurologija 1989;38:23-31.
25. Celers J, Netter R. Complications encéphalitiques de la rougeole en 1987 (1). Bull Acad Natl Méd 1989;173:133-39.
26. Enders-Ruckle G. Frequency, serodiagnosis and epidemiologic features of subacute-sclerosing panencephalitis and epidemiology and vaccination policy for measles in the FRG. 15th IABS Congress: Vaccinations in developing countries, La Guadeloupe. Dev Biol Standard 1978;41 195-207.
27. Mishra B, Kakkar N, Ratho RK, Singhi P, Prabhakar S. Changing trend of SSPE over a period of ten years. Indian J Public Health 2005;49 235-37.
28. Khare S, Kumari. S, Verghese T. Subacute sclerosing panencephalitis in Delhi. J Trop Pediatr 1994;40:326-28.
29. Khare S, Kumari S, Sehgal S. Sero-epidemiology of subacute sclerosing panencephalitis in Delhi. Indian J Med Res 1990;91:94-97.
30. Modarres SH, Ghofrani M. The epidemiology of subacute sclerosing panencephailitis (SSPE) in Northern Iran. Irn J Med Sci 1998;23 29.
31. Soffer D, Rannon L, Alter M, Kahana E, Feldman S. Subacute sclerosing panencephalitis: An epiderniologic study in Israel. Am J Epidemiol 1976;103:67-74.
32. Cianchetti C, Ferrante P, Marrosu MG. Subacute sclerosing panencephalitis in Italy. An epidemiological study. Acta Neurol Scand 1986;73:160-67.
33. Gray RH, Char G, Prabhakar P, Bainbridge R, Johnson B. Subacute sclerosing panencephalitis in Jamaica. WI Med J 1986;35 27-34.
34. Okuno Y, Nakao T, Ishida N et al. Incidence of subacute sclerosing panencephalitis following measles and measles vacdnation in Japan. Int J Epidemiol 1989;18:684-89.
35. Tukei PM, Kenya PR, Ensering H. An epidemiological study of subacute sclerosing panencephalitis in Kenya. East Afr Med J 1983;60 34-38.
36. Dixit VM, Hettiaratchi ES, Muoka T. A study of subacute sclerosing panencephalitis in Kenya. Dev Med Child Neurol 1981;23 208-16.
37. Haddad FS, Risk WS, Jabbour JT. Subacute sclerosing panencephalitis in the Middle East: Report of 99 cases. Ann Neurol 1977;1 211-17.
38. Baguley DM, Glasgow GL. Subacute sclerosing panencephalitis and Salk vaccine. Lancet 1973;2:763-65.
39. Morrow JI, Dewey KE, Swallow MW. Subacute sclerosing panencephalitis in Northern Ireland: Twenty years' experience. Ulster Med J 1986; 55:124-30.
40. Kondo K, Takasu T, Ahmed A. Neurological diseases in Karachi, Pakistan - elevated occurrence of subacute sclerosing panencephalitis. Neuroepidemiology 1988;7:66-80.
41. Milewska D, Kulczycki.J, Sobczyk W. [Computerized analysis of the database of SSPE patients treated at the 1st Neurological Clinic of the Institute of Psychiatry and Neurology in Warsaw in 1978-1995]. Neurol Neurochir Pol 1997;31:475-91.
42. Cernescu C, Popescu-Tismana G, Alaicescu M, Popescu L, Cajal N. The continuous decrease in the number of SSPE annual cases ten years after compulsory anti-measles immunization. Rev Roum Virol 1990;41 13-18.
43. Cemescu. C, Milea S, Berbescu C, Pastia M, Popescu L. S.S.P.E.: Some dues to pathogenesis from epidemiological data. Virologie 1988; 39:247-56.
44. Cernescu C, Cajal N, Popescu-Tismana. G. SSPE: Epidemiological and serological features in a series of cases recorded between 1975 and 1984. Viroloyie 1985;36:247-54.
45. Cernescu C, Milea S. Data on the incidence of subacute sclerosing panencephalitis (SSPE) in Romania. Virologie 1978;29:177-82.
46. Cianchetti C, Cao A. Mastropaolo C, Corda R. Subacute sclerosing pariencephalitis in Sardinia. Lancet 1979;1:829.
47. Moodie JW, MacKenzie DJ, Kipps A. Subacute sclerosing panence-phalitis (SSPE) in southern Africa. Recent additions to the SSPE registry. S Afr Med J 1980;58:964-67.
48. Ip P, Chung BHY, Wong VCN, Chan K-Y. Subacute sclerosing panencephalitis in children: Prevalence in South China. Paediatric Neurol 2004; 31:46-51.
49. Beersnia MF, Galama JM, Van Druten HA, Renier WO, Lucas CJ, Kapsenberg JG. Subacute sclerosing pariencephalitis in The Netherlands - 1976-1990. Int J Epidemiol 1992;21:583-88.
50. Onal AE, Gurses C, Direskeneli GS et al. Subacute sclerosing panencephalitis surveillance study in Istanbul. Brain Dev 2006; 28:183-89.
51. Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S, Okan M. Changing epidemiological features of subacute sclerosing panencephalitis. Infection 2001;29:192-95.
52. yalaz K. Anlar B, Renda Y, Aysun S, Topcu M, Ozdirim E. Subacute sclerosing panencephalitis in Turkey: Epidemiological features. J Trop Pediatr 1988;34:301-15.
53. Dyken P. Subacute sclerosing panencephalitis: Current status. Neurol Clin 1985;3:179-95.
54. Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. Risk factors in subacute sclerosing panencephalitis: A case-control study. Am J Epidemiol 1980;111:415-24.
55. Modlin IF, Halsey NA, Eddins DL et al. Epidemiology of subacute sclerosing panencephalitis. Pediatr 1979;94:231-36.
56. Modlin IF, Jabbour JT, Witte JJ, Halsey: NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 1977;59:505-12.
57. Jabbour IT, Duenas DA, Sever JL, Krebs HM, Horta-Barbosa L. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry. JAMA 1972;220:959-62.
58. Kulczycki J. The history of studies on subacute sclerosing patience-phalitis in Poland. Folia Neuropathol 1998;36 191-98.
59. Dyken P, Cunningham SC, Ward LC. Changing character of subacute sclerosing panencephalitis in the United States. Pediatr Neurol 1989;5:339-41.
60. Carman WF, Johnson S. Subacute sclerosing panencephalitis in South Africa. Trans R Soc Trop Med Hyg 1989;83:117-18.
61. Tan E, Namer U, Ciger A et al. The prognosis of subacute sclerosing panencephalitis in adults. Report of 8 cases and review of the literature. Clin Neurol Neurosury 1991;93:205-09.
62. Singer C, Lang AE, Suchowersky O. Adult onset subacute sclerosing panencephalitis: Case reports and review of the literature. Mov Disord 1997;12:342-53.
63. Prashanth IY, Taly AB, Ravi V, Sinha S, Arunodaya GR. Adult onset subacute sclerosing panencephalitis: Clinical profile of 39 patients from a tertiary care centre. J Neurol Neurosurg Psychiatry 2006; 77:630-33.
64. Detels F4 Brody IA. McNew J, Edgar AH. Further epidemiological studies of subacute sclerosing panencephalitis. Lancet 1973;2:11-14.
65. Bojinova VS, Dimova PS, Belopitova LD et al. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978-2002). Eur J Paediatr Neurol 2004;8:89-94.
66. Mackenzie DJM, Kipps A, McDonald R. Subacute sclerosing panencephalitis in Southern Africa. S Afr Med J 1975;49:2083-86.
67. Park SY, Kohl S. Subacute sclerosing panencephalitis in an identical twin. Pediatrics 2005;104:1390-94.
68. Tuxhorn IEB. Familial subacute sclerosing panencephalitis in two siblings. Pediatric Neurol 2004;31:291-94.
69. Vieker S, Schmitt JJ, Behrens C, Weissbrich B, Hartmann H. Subacute sclerosing panencehalitis in two brothers. Neuropediatrics 2003; 34:326-29.
70. Cernescu C, Milea S. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Romania between 1976-1982. Virologie 1983;34 239-50.
71. Tulchinsky TH. Prevention of measles in Israel: Short- and long-term intervention strategies. Isr J Med Sci 1091;27:22-29.
72. Naruszewicz-Lesiuk D, Iwinska-Buksowicz B, Wieczorkiewicz M, Kulczycki J, Gut W. [Subacute sclerosing panencephalitis. (SSPE) in Poland in 1996-1999, Phase VII of epidemiologic studies]. Neurol Neurochir Pol 2000;34:877-85.
73. Farrington CP. Subacute sclerosing panencephalitis in England and wales: transient effects and risk estimates. Stat Med 1991;10 1733-44.
74. Forcic D, Baricevic M, Zgorelec R et al. Detection and characterization of measles virus strains in cases of subacute sclerosing panencephalitis in Croatia. Virus Res 2004;99 51-56.
75. Santibanez S, Heider A, Gerike E, Agafonov A. Schreier E. Genotyping of measles virus isolates from Central Europe and Russia. J Med Virol 1999;58:313-20.
76. Wight C, Jin L, Nelson CS, Cosby SL, Padfield CJH. Case report: An autopsy-proven case of fulminant subacute sclerosing panencephalitis. Neuropathol Appl Neurobiol 2003;29:312-30.
77. Yamaguchi S. Identification of three lineages of wild measles virus by nucleotide sequence analysis of N, P, M, F and L genes in Japan. J Med Virol 1997;52:113-20.
78. Barrero PR, Grippo J, Viegas M, Mistchenko AS. Wild-type measles virus in brain tissue of children with subacute sclerosing panencephalitis, Argentina. Emerg Infect Dis 2003;9:1333-36.
79. Jin L, Beard S, Hunjan R, Brown DWG, Miller B. Characterization of 11 measles virus strains causing SSPE: A study of 11 cases. J Neurovirol 2002;8:335-44.
80. Miki K, Komase K, Mgone CS et al. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua New Guinea. J Med Virol 2002;68:105-12.
81. Suga S, Miyahara M, Obata M et al. Detection by polymerase chain reaction of wild-type measles virus genome in the cerebrospinal fluid of a patient with SSPE who had received measles vaccine. Clin Diagn Virol 1996;5:37-42.
82. Kawashima H, Miyajima T, Mori T et al. A case of intractable epilepsy positive for the detection of measles virus genome in the cerebrospinal fluid and peripheral mononuclear cells using reverse transcriptase polymerase chain reaction. Brain Dev 1996;18 220-23.
83. Sonoda S, Nakayama T. Detection of measles virus genome in lymphocytes from asymptomatic healthy children. J Med Virol 2001;65 381-87.
84. Rota JS, Wang ZD, Rota PA, Bellini WJ. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res 1994;31:317-30.
85. Cattaneo R, Schmid A, Spielhofer P et al. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 1989;173:415-25.
86. Rima BK, Earle JA, Yeo RP et al. Temporal and geographical distribution of measles virus genotypes. J Gen Virol 1995;76 1173-80.
87. Buckland R, Gerald C, Barker D, Wild F. Cloning and sequencing of the nucleoprotein gene of measles virus (Halle strain). Nucleic Acids Res 1988;16:11821.
88. Schmid A, Cattaneo R, Billeter MA. A procedure for selective full length cDNA cloning of specific RNA species. Nucleic Acids Res 1987;15 3987-96.
89. Komase K, Rima BK, Pardowitz I et al. A comparison of nucleotide sequences of measles virus L genes derived from wild-type viruses and SSPE brain tissues. Virology 1995;208:795-99.
90. Furukawa Y, Ayata M, Kimura M et al. Hemadsorption expressed by cloned H genes from subacute sclerosing panencephalitis (SSPE) viruses and their possible progenitor measles viruses isolated in Osaka, Japan. Microbiol Immunol 2001;45:59-68.
91. Homma M, Tashiro M, Konno H, Ohara Y, Hino M, Takase S. Isolation and characterization of subacute sclerosing panencephalitis virus (Yamagata-1 strain) from a brain autopsy. Microbiol Immunol 1982;26:1195-202.
92. Baczko K, Lampe J, Liebert UG et al. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology 1993;197 188-95.
93. Taylor MJ, Godfrey E, Baczko K, ter Meulen V, Wild TF, Rima BK. Identification of several different lineages of measles virus. J Gen Virol 1991;72:83-88.
94. Hotta H, Nihei Y, Abe Y et al. Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE. Microbiol Immunol 2006;50:525-34.
95. Baram TZ, Gonzalez-Gomez I, Xie ZD et al. Subacute sclerosing panencephalitis in an infant: Diagnostic role of viral genome analysis. Ann Neurol 1994;36:103-08.
96. Baricevic M, Forcic D, Santak M, Mazuran R. A comparison of complete untranslated regions of measles virus genomes derived from wild-type viruses and SSPE brain tissues. Virus Genes 2007;35:17-27. Epub 2006 Oct 13.
97. Kuhne M, Brown DW, Jin L. Genetic variability of measles virus in acute and persistent infections. Infect Genet Evol 2006;6:269-76. Epub 2005 Sept 19.
98. Dodson WE, Pasternak J, Trotter JL. Rapid deterioration in subacute sclerosing panencephalitis after measles immunisation. Lancet 1978;i:767-68.
99. Halsey NA, Schubert W, Jabbour JT, Preblud SR. Measles vaccine and the course of subacute sclerosing panencephalitis. Lancet 1978;2 8093):783.
100. Sever JL, Ellenberg JH, Krebs HM, Jabhour JT. Subacute sclerosing panencephalitis and measles vaccine. Pediatr Res 1974;8 418-19.
101. Wakefield AJ. Presentation at the National Information Center's 1st International Public Conference on Vaccination. Alexandria VA, Sept 13-15 1997.
102. Halsey NA, Modlin JF. Subacute sclerosing panencephalitis. Pediatric Neurol 1991;7:151.
103. Chiba ME, Saito M, Suzuki N, Honda Y, Yaegashi N. Measles infection in pregnancy. J Infect 2003;47:40-44.
104. Ohyama M, Fukui T, Tanaka Y et al. Measles virus infection in the placenta of monozygotic twins. Mod Pathol 2001;14:1300-03.
105. Ali ME, Albar HM. Measles in pregnancy: Maternal morbidity and perinatal outcome. Int J Gynaecol Obstet 1997;59:109-13.
106. Siegel M. Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study. JAMA 1973;226 1521-24.
107. Dao B, Koalaga AP, Ki Zerbo G, Bambara M, Bazie AJ. Measles and pregnancy. Apropos of 16 cases in Burkina Paso. J Gynecol Obstet Biol Reprod 1997;26:606-69.
108. Matsumoto Y, Morimoto I. Shibutani T et al. Measles encephalitis in early pregnancy and after delivery. J Infect Chemother 2005; 11:97-100.
109. Rosa C. Rubella and rubeola. Semin Perinatol 1998;22:318-22.
110. Eberhart-Phillips JC, Frederick PD, Baron RC et al. Measles in pregnancy: A descriptive study of 58 cases. Obstet Gynecol 1993; 82:797-801.
111. Mason WH. Measles. Adolesc Med 1995;6:1-14.
112. Hardy JB. Fetal consequences of maternal viral infections in pregnancy. Arch Otolaryngol 1973;98:218-27.
113. Jones P, Fine P, Piracha S. Crohn!s disease and measles [letter; comment]. Lancet 1997;349:473.
114. Dasopoulou M, Covanis A. Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatr 2004;93:1251-53.
115. Cruzado D, Massery-Spicher, Roux L, Delavelle J, Picard F, Haenggeli CA. Early onset and rapidly progressive SSPE. Eur J Paediatr 2002; 161:438-41.
116. Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada G. SSPE following neonatal measles infection. Pediatric Neurol 1999;20:63-65.
117. Zwiauer K, Forstenpointner E, Popow-Kraupp T, Hauser E, Jellinger KA. Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection. Lancet 1995;345:1124.
118. Simsek E, Ozturka A. Yavuz C, Kocabay K. Subacute sclerosing paneencephalitis (SSPE) associated with congenital measles infection. Turk J Pediatr 2005;47:58-62.
119. Jayawant S, Feyi-Waboso A, Wallace S et al. Retinitis and dementia in a pregnant girl: An unusual case. Eur J Paediatr Neurol 2000; 4:177-79.
120. Haraguchi T, Yabuki S. A case of measles encephaloneuropathy in a pregnant women. No To Shinkei 1998;50:761-65.
121. Belgamwar RB, Prasad D, Appaya P. Measles, mumps, rubella vaccine induced SSPE. J Indian Med Assoc 1997;95:594.